Browse > Article

Heterogenous Clinical Manifestations in Adult Patients with Late Diagnosis of Glycogen Storage Disease type Ia  

Kim, Yoo-Mi (Department of Pediatrics, College of Medicine, Pusan National University Children's Hospital)
Cheon, Chong Kun (Department of Pediatrics, College of Medicine, Pusan National University Children's Hospital)
Kim, Gu-Hwan (Medical Genetics Center, Asan Medical Center Children's Hospital University of Ulsan College of Medicine)
Yoo, Han-Wook (Medical Genetics Center, Asan Medical Center Children's Hospital University of Ulsan College of Medicine)
Publication Information
Journal of The Korean Society of Inherited Metabolic disease / v.15, no.1, 2015 , pp. 9-17 More about this Journal
Abstract
Glycogen storage disease (GSD) type Ia is rare inborn metabolic disorder, caused by glucose-6-phosphatase deficiency. It characterized by hepatomegaly, hypoglycemia, lactic acidosis, hypertriglyceridemia, and hyperuricemia and it is usually manifested in the infantile period. In addition, it is also associated with growth failure, pubertal delay, anemia, platelet dysfunction, osteopenia, and pulmonary hypertension. Hepatocellular adenoma and renal dysfunction are frequent late complications. Delayed diagnosis and inappropriate therapy lead to many complications such as growth failure, osteoporosis, refractory gout, renal failure, hepatocellular carcinoma (HCC), and pulmonary hypertension. Here, two Korean sisters diagnosed with GSD Ia, aged 33 and 36 respectively, were described and compared to recent articles about four adults with late diagnosis of GSD Ia. One sister had typical manifestations of GSD Ia including short stature (height, 145 cm), multiple hepatic adenoma, chronic kidney disease stage IV, and severe osteoporosis, whereas the older sister had normal stature (162 cm), one tiny hepatic nodule, and normal renal function. Direct sequencing of G6PC in two sisters identified a homozygous splicing mutation, c.645G>T, which is a prevalent mutation in Korea. Interestingly, our cases and four adults from recent reports had asymptomatic mild hypoglycemia and various manifestations including renal failure, HCC, fatty liver, or uncontrolled hyperlipidemia. These adult cases represent not only heterogenous phenotype to genotype within family members with GSD Ia but also long-term complications such as gouty arthritis, renal failure, and osteoporosis in untreated adult GSD Ia patients. In addition, lactic academia and hypertriglyceridemia are good markers of GSD Ia to distinguish from metabolic disease.
Keywords
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hicks J, Wartchow E, Mierau G. Glycogen storage diseases: a brief review and update on clinical features, genetic abnormalities, pathologic features, and treatment. Ultrastruct Pathol 2011;35:183-96.   DOI
2 Froissart R, Piraud M, Boudjemline AM, Vianey-Saban C, Petit F, Hubert-Buron A, et al. Glucose-6-phosphatase deficiency. Orphanet J Rare Dis 2011;20:27.
3 Chou JY, Matern D, Mansfield BC, Chen YT. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med 2002;2:121-43.   DOI
4 Moses SW. Historical highlights and unsolved problems in glycogen storage disease type 1. Eur J Pediatr 2002;161(Suppl 1):S2-9.   DOI
5 Lei KJ, Shelly LL, Pan CJ, Sidbury JB, Chou JY. Mutations in the glucose-6-phosphatase gene that causeglycogenstoragediseasetypeIa. Science 1993;262:580-3.   DOI
6 Lei KJ, Chen H, Pan CJ, Ward JM, Mosinger B Jr, Lee EJ, et al. Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-Ia mouse. Nat Genet 1996;13:203-9.   DOI
7 Talente GM, Coleman RA, Alter C, Baker L, Brown BI, Cannon RA, et al. Glycogen storage disease in adults. Ann Intern Med 1994;120:218-26.   DOI
8 Carvalho PM, Silva NJ, Dias PG, Porto JF, Santos LC, Costa JM. Glycogen Storage Disease type Ia - a secondary cause for hyperlipidemia: report of five cases. J Diabetes Metab Disord 2013;12:25.   DOI
9 Cassiman D, Libbrecht L, Verslype C, Meersseman W, Troisi R, Zucman-Rossi J, et al. An adult male patient with multiple adenomas and a hepatocellular carcinoma: mild glycogen storage disease type Ia. J Hepatol 2010;53:213-7.   DOI
10 Shieh JJ, Lu YH, Huang SW, Huang YH, Sun CH, Chiou HJ, et al. Misdiagnosis as steatohepatitis in a family with mild glycogen storage disease type Ia. Gene 2012;509:154-7.   DOI
11 Araoka T, Takeoka H, Abe H, Kishi S, Araki M, Nishioka K, et al. Early diagnosis and treatment may prevent the development of complications in an adult patient with glycogen storage disease type Ia. Intern Med 2010;49:1787-92.   DOI
12 Choi J, Ko JM, Kim GH, Yoo HW. Clinical Manifestation and Effect of Corn Starch on Height Growth in Korean Patients with Glycogen Storage Disease Type Ia. J Korean Soc Pediatr Endocrinol 2007;12:35-40.
13 Ki CS, Han SH, Kim HJ, Lee SG, Kim EJ, Kim JW, et al. Mutation spectrum of the glucose-6-phosphatase gene and its implication in molecular diagnosis of Korean patients with glycogen storage disease type Ia. ClinGenet 2004;65:487-9.
14 Chou JY, Matern D, Mansfield BC, Chen YT. Type I glycogen storage diseases: Disorders of the glucose-6-phosphatase complex. Curr Mol Med 2002;2:121-43.   DOI
15 Lei KJ, Chen YT, Chen H, Wong LJ, Liu JL, Mc Conkie-Rosell A, et al. Genetic basis of glycogen storage disease type Ia: prevalent mutations at the glucose-6-phosphatase locus. Am J Hum Genet 1995;57:766-71.
16 Shah KK, O'Dell SD. Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type Ia: a systematic review and meta-analysis. J Hum Nutr Diet 2013;26:329-39.   DOI
17 Matern D, Seydewitz HH, Bali D, Lang C, Chen YT. Glycogen storage disease type I: diagnosis and phenotype/genotype correlation. Eur J Pediatr 2002;161(Suppl 1):S10-9.   DOI
18 Nakamura T, Ozawa T, Kawasaki T, Nakamura H, Sugimura H. Glucose-6-phosphatase gene mutations in 20 adult Japanese patients with glycogen storage disease type Ia with reference to hepatic tumors. J Gastroenterol Hepatol 2001;16:1402-8.   DOI
19 Rake JP, Visser G, Labrune P, Leonard JV, Ullrich K, Smit GP, at al. Guidelines for management of glycogen storage disease type I -European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr 2002;161:S112-9.   DOI
20 Martens DH, Rake JP, Navis G, Fidler V, van Dael CM, Smit GP. Renal function in glycogen storage disease type I, natural course, and renopreservative effects of ACE inhibition. Clin J Am Soc Nephrol 2009;4:1741-6.   DOI
21 Araoka T, Takeoka H, Abe H, Kishi S, Araki M, Nishioka K, et al. Early diagnosis and treatment may prevent the development of complications in an adult patient with glycogen storage disease type Ia. Intern Med. 2010;49:1787-92.   DOI
22 Franco LM, Krishnamurthy V, Bali D, Weinstein DA, Arn P, Clary B,et al. Hepatocellular carcinoma in glycogen storage disease type Ia: a case series. J Inherit Metab Dis 2005;28:153-62.   DOI
23 Sakamoto A, Hayashi H, Sakamoto I, Isomoto I, Eguchi S, Takatsuki M, et al. Multiple hepatocellular adenomas in a patient with glycogen storage disease type I: various enhancement patterns in MRI with Gd-EOB-DTPA. Abdom Imaging 2012;37:239-43.   DOI
24 Ueno M, Murakami T, Takeda A, Kubota M. Efficacy of oral sildenafil in a beraprost-treated patient with severe pulmonary hypertension secondary to type I glycogen storage disease. Circ J 2009;73:1965-8.   DOI